Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 29;8(17):eabm9825.
doi: 10.1126/sciadv.abm9825. Epub 2022 Apr 27.

COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity

Affiliations

COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity

Janina I Steinert et al. Sci Adv. .

Abstract

We examine heterogeneity in COVID-19 vaccine hesitancy across eight European countries. We reveal striking differences across countries, ranging from 6.4% of adults in Spain to 61.8% in Bulgaria reporting being hesitant. We experimentally assess the effectiveness of different messages designed to reduce COVID-19 vaccine hesitancy. Receiving messages emphasizing either the medical benefits or the hedonistic benefits of vaccination significantly increases COVID-19 vaccination willingness in Germany, whereas highlighting privileges contingent on holding a vaccination certificate increases vaccination willingness in both Germany and the United Kingdom. No message has significant positive effects in any other country. Machine learning-based heterogeneity analyses reveal that treatment effects are smaller or even negative in settings marked by high conspiracy beliefs and low health literacy. In contrast, trust in government increases treatment effects in some groups. The heterogeneity in vaccine hesitancy and responses to different messages suggests that health authorities should avoid one-size-fits-all vaccination campaigns.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.. COVID-19 vaccine hesitancy by gender.
Participants were considered vaccine hesitant if they reported being either unsure whether they would get vaccinated against COVID-19 or certain that they would not get vaccinated. Participants who had already received one or two vaccine shots were coded as not hesitant.
Fig. 2.
Fig. 2.. Acceptance of different COVID-19 vaccines among unvaccinated participants with conditional willingness.

References

    1. Orenstein W. A., Ahmed R., Simply put: Vaccination saves lives. Proc. Natl. Acad. Sci. U.S.A. 114, 4031–4033 (2017). - PMC - PubMed
    1. Doherty M., Buchy P., Standaert B., Giaquinto C., Prado-Cohrs D., Vaccine impact: Benefits for human health. Vaccine 34, 6707–6714 (2016). - PubMed
    1. Liu L., Johnson H. L., Cousens S., Perin J., Scott S., Lawn J. E., Rudan I., Campbell H., Cibulskis R., Li M., Mathers C., Black R. E.; Child Health Epidemiology Reference Group of WHO and UNICEF , Global, regional, and national causes of child mortality: An updated systematic analysis for 2010 with time trends since 2000. Lancet 379, 2151–2161 (2012). - PubMed
    1. World Health Organization, The Power of Vaccines: Still not fully utilized (2020); https://www.who.int/publications/10-year-review/chapter-vaccines.pdf.
    1. Reno C., Maietti E., Fantini M. P., Savoia E., Manzoli L., Montalti M., Gori D., Enhancing COVID-19 vaccines acceptance: Results from a survey on vaccine hesitancy in Northern Italy. Vaccine 9, 378 (2021). - PMC - PubMed